Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Search Results for "deer":

Results: 2,490

Quotes

DEER Al Deera Holding Co KSCC Stock - Kuwait City equities DEER Deer Consumer Prodct Stock - OTC Markets equities DE Deere & Company Stock - NYSE equities DEER Deere & Co DRC Stock - CBOE Canada equities DE Deere & Company Stock - Xetra equities DERA Deera Investment&RE Development Co Stock - Amman equities 301332 Guangdong Deerma Technology Co Ltd Stock - Shenzhen equities DEEC34 Deere & Co Stock - B3 equities
Show all (16)

News

Eton Pharmaceuticals licenses Increlex rights abroad
By Investing.com

DEER PARK, Ill. - Eton Pharmaceuticals, Inc (NASDAQ:ETON), a company specializing in rare disease treatments with a market capitalization of $348 million and an impressive 246% return over the past...

John Deere, Dovetail unveil women's farmwear line
By Investing.com

MOLINE, Ill. - In an initiative to support the role of women in agriculture, Dovetail Workwear has partnered with John Deere (NYSE: DE) to launch a new line of apparel and gear tailored for female...

Exro Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
By Investing.com

CALGARY, AB, March 31, 2025 /PRNewswire/ -  Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean-technology company that provides proprietary motor-control and...

Show all (1,503)

Analysis

Thematic ETFs: The Good, The Bad, and The Ugly
By Tony Dong

Thematic ETFs sit in a weird niche between sector ETFs and stock picking. They’re usually built around a specific idea or long-term trend, like clean energy, artificial intelligence, or space...

This 'Secret' Growth Stock Has 25% Upside in 2025
By Brett Owens

I’d like to share my exclusive “Made for 2025” Dividend Plan with you. It’s a simple, safe strategy that identifies dividend stocks with payouts set to surge higher. As these divvies pop, so do their...

Valeant Pharmaceuticals: The Perils Of The Debt Acquisition Model
By EconMatters

Valeant Pharmaceuticals (NYSE:VRX) need a 'fix it" third party to come in stop the bleeding. Moreover, the current management team is stuck in the deer in headlights mode, and needs to start taking...

Show all (971)
Results: 16

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 1,503

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 971

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Apple
Continue with Google
or
Sign up with Email